Volume 15

Issue 1

Article 13

2007

A new detection technique for fluoroquinolone-conjugated
proteins by high performance liquid chromatography with UV/
fluorescence detectors

Follow this and additional works at: https://www.jfda-online.com/journal

Recommended Citation
Hung, S.-W.; Shih, C.-W.; Chen, B.-R.; Tu, C.-Y.; Ling, Y.-F.; Tsou, L.-T.; Ho, S.-P.; and Wang, W.-S. (2007) "A
new detection technique for fluoroquinolone-conjugated proteins by high performance liquid
chromatography with UV/fluorescence detectors," Journal of Food and Drug Analysis: Vol. 15 : Iss. 1 ,
Article 13.
Available at: https://doi.org/10.38212/2224-6614.2448

This Original Article is brought to you for free and open access by Journal of Food and Drug Analysis. It has been
accepted for inclusion in Journal of Food and Drug Analysis by an authorized editor of Journal of Food and Drug
Analysis.

71
Journal of Food and Drug Analysis, Vol. 15, No. 1, 2007, Pages 71-74

藥物食品分析

第十五卷

第一期

A New Detection Technique for Fluoroquinolone-Conjugated
Proteins by High Performance Liquid Chromatography
with UV/Fluorescence Detectors
SHAO-WEN HUNG, CHING-WEN SHIH, BO-RUI CHEN, CHING-YU TU, YU-FEN LING,
LI-TSE TSOU, SHU-PENG HO AND WAY-SHYAN WANG*
Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University,
250 Kuo Kuang Rd., Taichung 402, Taiwan, R.O.C.
(Received: July 18, 2006; Accepted: November 7, 2006)

ABSTRACT
This study was aimed to develop a simple, fast, and reliable technique to detect fluoroquinolones (FQs) -conjugated bovine
serum albumin (BSA). Four tested FQs, enrofloxacin, ofloxacin, danofloxacin, and orbifloxacin, were conjugated with BSA by
following the N-hydroxysuccinimide ester method. The technique was designed according to the different absorption characteristics of the FQs and BSA; FQs can be detected by both UV and fluorescence detectors, but BSA can only be detected by UV. The
results demonstrated that the developed method was efficient in detecting FQs-BSA conjugates. In addition, the method not only
trace the FQs and BSA conjugation responses but also can be used to estimate the level of FQs-BSA conjugation. Therefore, this
technique is a valuable tool for the detection drug-carrier-conjugated antigens, especially for FQs-BSA-conjugates during the production of anti-FQs monoclonal antibodies.
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INTRODUCTION
Fluoroquinolones (FQs) are currently used for the
treatment of invasive and systemic bacterial infections,
such as upper and lower respiratory infections, gonorrhea,
bacterial gastroenteritis, skin and soft tissue infections,
and urinary tract infections that occur in humans and
animals(1). Most of FQs such as enrofloxacin, ofloxacin,
danof loxacin, and orbif loxacin are bacteriostatic at low
concentrations and bactericidal at high concentrations.
They are more active against most Gram-negative pathogens, including Pseudomonas aeruginosa and the Enterobacteriaceae, than Gram-positive bacteria(2).
Serum albumins are the major proteins in the circulatory system of animals and contribute to the osmotic
blood pressure. They play a dominant role in drug disposition and efficacy(3). Many drugs can bind reversibly to
albumins, which then function as carriers. Serum albumins often increase the apparent solubility of hydrophobic
drugs in plasma and thus modulate their delivery to cells.
Furthermore, the molecular weight (MW) of some drugs,
like antibiotics, is too low to raise their antibodies. Therefore, for these low MW drugs, also called haptens, albumins can act as carrier proteins. When hatpens are conjugated with carrier proteins, their MWs become larger and
thus can stimulate the production of anti-hatpen antibodies. It is therefore necessary to investigate the conjugation
* Author for correspondence. Tel: +886-4-22840894 ext. 508;
Fax: +886-4-22862073; E-mail: wswang@dragon.nchu.edu.tw

of FQs and bovine serum albumin (BSA) (4) in order to
gain a better understanding of the processes involved.
Drug residues in animal tissues and milk pose a
potential threat to human health. There is an obvious
need for a rapid and accurate method to detect the residual
drug in edible animal tissues in order to protect consumers’ health. There are many techniques currently being
employed to analyze drug residues, including gel-filtration
chromatography, electrophoresis, ultracentrifugation,
immuno-diffusion, chemical analysis, and isotope labeling analysis(5). Omura et al.(6) reported that HPLC with
mass spectrometry and proton nuclear magnetic resonance
(1H-NMR) detector was capable of coupling the product
of 2’-deoxycytidine, and this method can be efficacious in
sorting productive components. Duan and Yuan (1) used
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), FeCl 3 colorimetry, and UV/VIS scanning
methods to ensure that the production of ciprofloxacinBSA was complete. They were able to detect the conjugated protein. However, these techniques are very complicated and expensive to perform. A cheaper and simpler
procedure is demanded.
FQs are readily detected with UV/VIS and f luorescence spectroscopy, which are powerful tools for the
study of the reactivity in the chemical and biological
systems(4,7). Therefore, the purpose of this study was to
estimate the extent of FQ-BSA conjugations by HPLC
with UV/fluorescence detectors.
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MATERIALS AND METHODS
I. Chemicals
In this study, four fluoroquinolones (FQs) were used:
enrofloxacin (Bayer, Wuppertal, Germany), danofloxacin
(Pfizer, New York, NY, USA), ofloxacin (Sigma, Louis,
MO, USA), and orbifloxacin (Dainippon Pharmaceutical,
Osaka, Japan) (Figure 1). The carrier protein, BSA, and
N-hydroxysuccinimide (NHS), 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), and dimethylformamide
(DMF) were purchased from Sigma. Trifluoroacetic acid
(TFA) was from Bakers (Phillipsburg, NJ, USA).
II. Apparatus
The H PLC system consisted of a LC1022 Plus
(Perkin-Elmer, Bridgeport, CT, USA), Degasys DG-1210
(Unif lows, Tokyo, Japan), a chromatointegrator (PE
Nelson 1022; Perkin-Elmer), a UV/VIS detector (LC295)
(Perkin-Elmer, Bridgeport, CT, USA) and a fluorescence
detector (TEC A4-2100A) (St. John Associates, Beltsville,
MD, USA). FQ-BSA conjugates were monitored by absorbance at 280 nm in UV detector or by emission at 450 nm
in fluorescence detector while excited at 290 nm.
III. Preparation of Conjugated Proteins of Fluoroquinolones and BSA
As shown in Figure 2, the method described by Watanabe et al.(8) was used with modification. The haptens,
namely enrofloxacin, ofloxacin, danofloxacin, and orbif loxacin, were individually conjugated with the carrier
protein, BSA, by NHS ester method. 0.1 mM of each FQ,
0.5 mM NHS and 0.5 mM EDC were solublized in 1 mL
of DMF and incubated for 24 hr at room temperature with
constant stirring. This solution was labeled as solution A
(pH 6.0). One hundred milligrams BSA (H 2N-E-A-H-K-

(A)

H3C

S-E-) was dissolved in 10 mL of 0.01 M PBS and labeled
as solution B. Solution A was dripped into solution B very
slowly while being mixed. The mixed solution was stirred
for 3 hr at room temperature in the dark and then dialyzed
against PBS (pH 7.4) at 4°C for six days. The Coomassie
plus protein assay reagent kit (Pierce, Rockford, IL, USA)
was used to determine the conjugated protein concentration. The conjugated proteins were concentrated using the
Speed Vac SC 110-120 (Savant, Holbrook, NY, USA) and
stored at -80°C until use.
IV. Detection of the Fluoroquinolones-BSA Conjugated
Proteins
BSA, four FQs (enrofloxacin, ofloxacin, danofloxacin,
and orbifloxacin), and four conjugated proteins, FQ-BSA,
were diluted with PBS to the final concentrations 2 mg/
mL, 20 µg/mL, and 800 µg/mL, respectively. A volume
of 20 μL of each solution above was injected into the
HPLC system. With these amounts of BSA, FQ-BSA
injected, we could get the best HPLC chromatograms.
Furthermore, no derivative procedure was used for the
fluorescence analysis. The mobile phase, acetonitrile (with
0.05% TFA) and double distilled water (with 0.05% TFA)
at a ratio of 60:40 (v/v) was first degassed using Degasys
DG-1210. The sample solutions were eluted and resolved
using a Cosmosil 5C18-AR-300 column (4.6 × 250 mm)
(Nacalai, Kyoto, Japan). The f low rate was 1 mL/min.
The combined detectors, namely UV/VIS and fluorescence
detectors, were used to detect the FQs and conjugated
proteins of FQs-BSA. Finally, the data was analyzed with
a chromatointegrator.

RESULTS
Twenty microliter of BSA at 2 mg/mL, which served
as a control, were injected into the HPLC system with
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Figure 1. The structures of four fluoroquinolones. (A) enrofloxacin; (B) ofloxacin; (C) danofloxacin; (D) orbifloxacin.
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Figure 2. The N-hydroxysuccinimide ester method used for the conjugation of fluoroquinolone with BSA. The fluoroquinolones used
included enrofloxacin, ofloxacin, danofloxacin, and orbifloxacin. The abbreviations used are as follows: N-hydroxysuccinimide (NHS),
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), dimethylformamide (DMF), and bovine serum albumin (BSA).

UV/f luorescence detectors. An obvious peak of BSA
appeared at 15.693 min under the UV detector, but there
was no signal for it under the fluorescence detector at the
same time point as shown in Figure 3. Twenty microliter
of enrofloxacin, ofloxacin, danofloxacin, or orbifloxacin
at 20 μg/mL were analyzed by HPLC with UV/f luorescence detectors. There were obvious peaks of enrofloxacin, ofloxacin, danofloxacin, and orbifloxacin at 12.897,
10.875, 11.978, and 12.235 min, respectively under both
UV and f luorescence (Figure 3). By the same method,
we could detect the conjugated proteins. Distinct peaks
of enrofloxacin-BSA, ofloxacin-BSA, danofloxacin-BSA,
and orbif loxacin-BSA were revealed at 16.600, 16.335,
16.235, and 17.335 min, respectively (Figure 3). According to the above results, we concluded that the established
HPLC method with UV/fluorescence detectors was useful
to detect the conjugated proteins of FQs-BSA.

DISCUSSION
FQs are extensively used in veterinary medicine,
so it is very important to detect their residues in edible
animal tissues due to public health concerns. However,
currently no simple and reliable detection kits are available for residual FQs. Because FQs are haptens, they need
to be conjugated with high MW carrier proteins to raise
anti-FQs antibodies(9). Therefore, a detection method for

monitoring the conjugation of FQs and BSA during the
combination stage is needed.
Pauillac et al.(10) reported that 200 to 300 nm UV
absorbance scanning from 200 to 300 nm was suitable for
the detection of the tested hapten 4-acetyl benzoic acid
(ABA) and the carrier protein BSA. Their results showed
that ABA absorbs UV in a range from 210 to 254 nm while
BSA absorbs UV in a range of 210 to 280 nm. Furthermore,
Duan and Yuan(1) indicated that the absorption peaks for
ciprof loxacin-BSA and BSA were 271 nm and 275 nm,
respectively. In the present study, our results suggest that
the appropriate absorption wavelength range for tested FQs,
FQs-BSA, and BSA located between 280 nm and 450 nm.
In this study, the conjugation of FQs with BSA was
successfully established by N-hydroxysuccinimide ester
method and analyzed by HPLC with both f luorescence
and UV detectors. Compared with the method employed
by Duan and Yuan(1), our technique was much easier and
cheaper for detecting FQs-BSA conjugated proteins and
can be used to estimate the degree of conjugation according
to integrated areas in the chromatograms. The technique
would be of value in the production of anti-FQs antibodies
and the development of a commercial detection kit for FQs.
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Figure 3. Detection of the fluoroquinolones-BSA conjugated proteins by using HPLC with UV and fluorescence detectors. Twenty µg/mL
of fluoroquinolones respectively included enrofloxacin A1, ofloxacin B1, danofloxacinC1, and orbifloxacin D1, 2 mg/mL of BSA A2, B2, C2,
D2
, and 800 µg/mL of conjugated proteins of enrofloxacin-BSA A3, ofloxacin-BSA B3, danofloxacin-BSAC3, and orbifloxacin-BSA D3 were
injected into HPLC system and detected with UV (upper curve) and fluorescence (lower curve) detectors.
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